Technologies de surveillance de la glycémie pour la gestion du diabète insulinodépendant
Statut du projet: Terminé
Utilisateur(s) des connaissances
Santé Alberta, Ministère de la Santé de Colombie-Britannique
Source(s) de financement
Instituts de recherche en santé du Canada (IRSC), dans le cadre de l’Alliance pour des données probantes de la Stratégie de recherche axée sur le patient (SRAP), Organisation mondiale de la Santé, Alberta Health Services
Objectif du projet
Évaluer : 1) l’efficacité clinique des glucomètres; 2) les perspectives et les expériences des patients relatives aux glucomètres; 3) la rentabilité et l’incidence budgétaire potentielle de l’utilisation de glucomètres par rapport aux dispositifs actuels de gestion de la glycémie.
Approche de recherche
Analyse environnementale, Revue systématique ciblée, Revue des lignes directrices
Responsables du projet
Fiona Clement
Fiona Clement has extensive training in Health Services Research, Health Economics and Health Policy. She is the Director of the Health Technology Assessment Unit within the O’Brien Institute of Public Health, University of Calgary; a policy responsive research unit that completes evidence synthesis, economic evaluations, health technology assessments and reassessments in response to decision-makers’ needs. Her research interests include drug and non-drug technology reimbursement and cost containment policy, evidence in decision-making, and evidence in health policy development.
Dr. Clement was selected as the Canadian Harkness fellow in 2014; a unique opportunity to study US healthcare policy. She has also received the Maurice McGregor Award for outstanding leadership and excellence in HTA in Canada. She is the first from Alberta to be awarded either of these awards. As a result, in 2015, she was named one of Calgary’s Top 40 under 40 for her work in health policy.
Fiona Clement
University of Calgary
Fiona Clement has extensive training in Health Services Research, Health…